Neurogene Inc (NGNE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $495.37M
Last updated: Nov 17, 2026 at 11:06 AM ET
Neurogene Inc (NGNE) Earnings: Report Dates and Results
Neurogene (NGNE) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Neurogene reported EPS of -$1.05, above the -$1.49 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
NGNE has an expected report date of Mar 22, 2027.
Earnings History
Of the 38 quarters below that had an estimate, NGNE beat 22, missed 15 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2018, when EPS landed 204.76% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$1.05 | -$1.49 | -$1.59 - -$1.36 | +29.53% | Beat | N/A | 5 | 3 up, 3 down | Nov 9, 2026 |
| Jun 30, 2026 | -$1.53 | -$1.40 | -$1.44 - -$1.30 | -9.29% | Miss | N/A | 2 | 1 up, 0 down | Aug 11, 2026 |
| Mar 31, 2026 | -$1.39 | -$1.27 | -$1.68 - -$1.00 | -9.05% | Miss | N/A | 6 | 3 up, 1 down | May 12, 2026 |
| Dec 31, 2025 | -$1.13 | -$1.24 | -$1.64 - -$1.01 | +8.87% | Beat | N/A | 4 | 0 up, 0 down | Mar 24, 2026 |
| Sep 30, 2025 | -$0.99 | -$1.09 | -$1.09 - -$1.09 | +9.17% | Beat | N/A | 1 | 0 up, 0 down | Nov 13, 2025 |
| Jun 30, 2025 | -$1.05 | -$1.16 | N/A | +9.48% | Beat | N/A | 1 | 0 up, 0 down | Aug 11, 2025 |
| Mar 31, 2025 | -$1.08 | -$1.12 | N/A | +3.57% | Beat | N/A | 1 | 0 up, 0 down | May 9, 2025 |
| Dec 31, 2024 | -$0.99 | -$1.13 | -$1.31 - -$1.03 | +12.39% | Beat | N/A | 6 | 1 up, 1 down | Mar 24, 2025 |
| Sep 30, 2024 | -$1.19 | -$1.22 | -$1.34 - -$1.15 | +2.46% | Beat | N/A | 6 | 0 up, 0 down | Nov 18, 2024 |
| Jun 30, 2024 | -$1.09 | -$1.03 | N/A | -5.83% | Miss | N/A | N/A | N/A | Aug 9, 2024 |
| Mar 31, 2024 | -$1.00 | -$0.95 | N/A | -5.26% | Miss | N/A | N/A | N/A | May 10, 2024 |
| Dec 31, 2023 | -$1.51 | -$1.17 | N/A | -29.06% | Miss | N/A | N/A | N/A | Mar 26, 2024 |
| Sep 30, 2023 | -$0.41 | -$0.03 | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Nov 14, 2023 |
| Jun 30, 2023 | -$0.04 | -$0.04 | N/A | 0.00% | In line | N/A | N/A | 0 up, 0 down | Aug 10, 2023 |
| Mar 31, 2023 | -$0.26 | -$0.22 | N/A | -18.18% | Miss | N/A | N/A | N/A | May 10, 2023 |
| Dec 31, 2022 | -$0.24 | -$0.19 | N/A | -26.32% | Miss | N/A | N/A | N/A | Mar 29, 2023 |
| Sep 30, 2022 | -$0.24 | -$0.30 | N/A | +21.13% | Beat | N/A | N/A | N/A | Dec 29, 2022 |
| Jun 30, 2022 | -$0.28 | -$0.30 | N/A | +6.67% | Beat | N/A | N/A | N/A | Aug 9, 2022 |
| Mar 31, 2022 | -$0.28 | -$0.30 | N/A | +6.04% | Beat | N/A | N/A | N/A | Jun 28, 2022 |
| Dec 31, 2021 | -$0.28 | -$0.30 | N/A | +5.31% | Beat | N/A | N/A | N/A | Mar 30, 2022 |
| Sep 30, 2021 | -$0.28 | -$0.28 | N/A | -0.61% | Miss | N/A | N/A | N/A | Dec 29, 2021 |
| Jun 30, 2021 | -$0.27 | -$0.26 | N/A | -3.05% | Miss | N/A | N/A | N/A | Sep 28, 2021 |
| Mar 31, 2021 | -$0.27 | -$0.23 | N/A | -18.42% | Miss | N/A | N/A | N/A | Jun 28, 2021 |
| Dec 31, 2020 | -$0.22 | -$0.24 | N/A | +9.95% | Beat | N/A | N/A | N/A | Mar 30, 2021 |
| Sep 30, 2020 | -$0.04 | -$0.04 | N/A | +9.09% | Beat | N/A | N/A | N/A | Nov 9, 2020 |
| Jun 30, 2020 | -$0.20 | -$0.21 | N/A | +4.76% | Beat | N/A | N/A | N/A | Aug 12, 2020 |
| Mar 31, 2020 | -$0.18 | -$0.23 | N/A | +21.74% | Beat | N/A | N/A | N/A | Jun 29, 2020 |
| Dec 31, 2019 | -$0.23 | -$0.28 | N/A | +17.86% | Beat | N/A | N/A | N/A | Mar 30, 2020 |
| Sep 30, 2019 | -$2.26 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | Dec 29, 2019 |
| Jun 30, 2019 | -$0.09 | -$0.05 | N/A | -80.00% | Miss | -175.0% | N/A | N/A | Aug 7, 2019 |
| Mar 31, 2019 | -$0.09 | -$0.23 | N/A | +60.87% | Beat | N/A | N/A | N/A | May 6, 2019 |
| Dec 31, 2018 | -$0.21 | -$0.16 | N/A | -32.91% | Miss | N/A | N/A | N/A | Mar 30, 2019 |
| Sep 30, 2018 | -$0.64 | -$0.21 | N/A | -204.76% | Miss | N/A | N/A | N/A | Nov 7, 2018 |
| Jun 30, 2018 | $0.12 | -$0.59 | N/A | +120.34% | Beat | N/A | N/A | N/A | Aug 8, 2018 |
| Mar 31, 2018 | -$0.62 | -$0.66 | N/A | +6.06% | Beat | N/A | N/A | N/A | Jun 29, 2018 |
| Dec 31, 2017 | -$0.69 | -$0.57 | N/A | -21.05% | Miss | N/A | N/A | N/A | Mar 30, 2018 |
| Sep 30, 2017 | -$0.50 | -$0.59 | N/A | +15.25% | Beat | N/A | N/A | N/A | Nov 8, 2017 |
| Jun 30, 2017 | -$0.59 | -$0.51 | N/A | -15.69% | Miss | N/A | N/A | N/A | Aug 8, 2017 |
| Mar 31, 2017 | -$0.36 | -$0.51 | N/A | +29.41% | Beat | N/A | N/A | N/A | Jun 29, 2017 |
| Dec 31, 2016 | -$0.48 | -$0.51 | N/A | +5.88% | Beat | N/A | N/A | N/A | Mar 30, 2017 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$4.25, after -$4.27 the year before. It was -$2.20 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$4.25 | N/A |
| Dec 31, 2024 | -$4.27 | N/A |
| Dec 31, 2023 | -$2.22 | N/A |
| Dec 31, 2022 | -$1.04 | N/A |
| Dec 31, 2021 | -$1.10 | N/A |
| Dec 31, 2020 | -$0.64 | N/A |
| Dec 31, 2019 | -$2.67 | N/A |
| Dec 31, 2018 | -$1.35 | N/A |
| Dec 31, 2017 | -$2.14 | N/A |
| Dec 31, 2016 | -$2.20 | N/A |
Frequently Asked Questions About NGNE
When is Neurogene's next earnings date?
Neurogene's next earnings report is expected for Mar 22, 2027.
Did NGNE beat earnings estimates last quarter?
Yes. Neurogene reported EPS of -$1.05 for the quarter ended Sep 30, 2026, above the -$1.49 estimate, a 29.53% surprise.
What EPS do analysts expect from NGNE next quarter?
The consensus EPS estimate for Neurogene for the quarter ending Dec 31, 2026 is -$1.38 from 12 analysts, with estimates from -$1.61 to -$1.04.
How often does NGNE beat earnings estimates?
Neurogene beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +6.84%.
NGNE pages: Overview, Earnings, Forecast, Financials, Competitors